Regulus Therapeutics | Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data


Eps Cambiamento Data
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Alterity Therapeutics Limited AUD 0 0 2023-12
AstraZeneca USD 2.12 0.26 2025-12
Biogen USD 1.99 2.82 2025-12
Celldex Therapeutics USD -1.01 0.16 2025-09
Cipla INR 15.2 1.52 2025-12
Clal Biotechnology ILS -0.04 0.1 2022-12
Compugen USD -0.08 0 2025-09
CSL USD 2.06 2.2 2025-06
Gilead Sciences USD 1.86 0.61 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Grifols EUR 0.26 0.06 2025-09
Immunic USD -0.24 0.03 2024-09
Incyte USD 1.8 0.46 2025-12
Intrexon USD -0.1 0.03 2024-06
Ionis Pharmaceuticals USD -0.8 1.5 2025-09
Lexicon Pharmaceuticals USD -0.17 0.02 2024-06
Ligand Pharmaceuticals USD 3.09 1.49 2025-09
Merck USD 2.04 0.54 2025-12
Omeros USD -1.12 0.37 2024-06
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR -0.67 3.62 2025-12
Takeda JPY 65.74 73.57 2025-12


Regulus Therapeutics Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.